Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Hatvan – page 12

480 clinical trials in Hatvan, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hatvan at a glance
480
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

480 trials in Hatvan

Open in trial search

Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Aveo Pharmaceuticals Inc.

Study on BI-1808 and Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI-1808
  • Sponsor:BioInvent International AB

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Asthma

Recruiting

Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Salbutamol
  • Sponsor:Novartis Pharma AG

Psoriasis

Recruiting

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Sun Pharmaceutical Industries Limited

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Astrazeneca AB

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Asthma

Recruiting

Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:Novartis Pharma AG

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Nykode Therapeutics ASA

Migraine+2

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Hatvan

What the registry says about research in the country

01 Cardiovascular Research

Extensive clinical trials focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions, including studies on new medications for heart failure management.

  • Heart Failure Treatment Studies
  • Cardiovascular Disease Prevention
  • Atrial Fibrillation Management

Advanced research evaluating treatments for both preserved and reduced ejection fraction heart failure.

02 Respiratory Medicine

Research initiatives examining treatments for chronic respiratory conditions, with particular focus on asthma and COPD management.

  • Asthma Control Studies
  • COPD Treatment Evaluation
  • Respiratory Drug Development

Innovative trials testing new inhalation devices and medication combinations.

03 Women's Health

Clinical investigations into reproductive health and women's medical conditions, including contraceptive technologies and menstrual health management.

  • Contraceptive Development
  • Primary Dysmenorrhea Treatment
  • Reproductive Health Solutions

Studies evaluating both hormonal and natural treatment approaches.

04 Metabolic Disorders

Research programs targeting metabolic conditions, with emphasis on obesity and lipid disorders management.

  • Obesity Treatment Studies
  • Hypertriglyceridemia Research
  • Cardiovascular Risk Management

Innovative approaches to treating severe metabolic disorders and their complications.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.